TE_38970

Basic information Differential Expression Stage analysis Survival analysis Correlation analysis

TE family HERV-Fc1_LTR1
TE superfamily ERV1
TE class LTR
Gene -
Class Intergenic
Coding Non-coding
Tumor-specific score 1.13
Counts of samples TCGA_tumor:0; TCGA_normal:0; GTEx:0
TSS chrY(-):18295992



Transcript isoforms

Transcript_ID Gene Class Coding ORF Position
teRNA_38970.1 - Intergenic Non-coding Non-coding chrY(-):18290999,18291019,18295743,18295993
teRNA_38970.2 - Intergenic Non-coding Non-coding chrY(-):18291523,18291543,18295743,18295993
teRNA_38970.3 - Intergenic Non-coding Non-coding chrY(-):18291518,18291538,18295743,18295993
teRNA_38970.4 - Intergenic Non-coding Non-coding chrY(-):18291518,18291538,18294228,18295614,18295743,18295993
teRNA_38970.5 - Intergenic Non-coding Non-coding chrY(-):18291523,18291543,18294228,18295614,18295743,18295993
teRNA_38970.6 - Intergenic Non-coding Non-coding chrY(-):18290999,18291019,18294228,18295614,18295743,18295993


GTEx

The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.




TCGA

The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).




GTEx

The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.




TCGA

The expression of TE-initiated transcript across 33 cancer types from The Cancer Genome Atlas (TCGA).